|1.||Hypertension (High Blood Pressure)
04/01/1983 - "A crossover trial of oxdralazine in hypertension."
12/01/1980 - "1. The antihypertensive effect of the new drug, SKF 92 657, a hydrazinopyridazine derivative, possessing both beta-adrenoreceptor-blocking and vasodilating properties, was investigated in essential hypertension. "
01/01/1983 - "After an initial placebo period of four weeks 24 patients with primary hypertension were treated with prizidilol, a hydrazinopyridazine derivative with combined vasodilator and non-selective beta-adrenoceptor blocking actions, for a dose titration period of 14 weeks. "
08/01/1981 - "Thirty-one patients with moderate and severe essential hypertension completed a comparative study of oxdralazine and dihydralazine. "
08/01/1981 - "Comparative study of oxdralazine and dihydralazine in essential hypertension."